Our latest news, insights & events
Herzog, Fox & Neeman acted for 888 US Inc., a wholly owned subsidiary of 888 Holdings Plc, in its acquisition
Herzog Fox & Neeman Represents 888 in Acquisition of AAPN from Avenue OLG Entertainment
Herzog Fox & Neeman represented CodeMonkey Studio Inc. in their acquisition by TAL Education Group. CodeMonkey’s specialty is game-like computer
Herzog Fox & Neeman Represents CodeMonkey Studio Inc. in Buy-Out
In a precedential ruling, a Delaware Court has allowed Fresenius to withdraw from a $4.75 billion acquisition of Acorn Pharmaceuticals
The Start-Up’s Worst Nightmare: Precedential US Ruling on Exits
Herzog Fox & Neeman advised Linse Capital in a $63 million investment in Hod HaSharon-based Valens. Linse was advised by Hanan
Herzog Fox & Neeman Advises Linse Capital Through Investment in Valens
In one of the biggest and most successful exits in Israeli tech history, cybersecurity start-up, Sygnia, founded in 2015 by
Team8’s Sygnia bought by Singaporean Temasek
Herzog Fox & Neeman’s Hi-Tech Department represented Perforce in its USD 200 million acquisition of Perfecto, experts in mobile quality
Herzog Fox & Neeman Represents Perforce in $200m Perfecto Acquisition
Herzog Fox & Neeman represented Vista in acquisition of Fortissimo’s solutions firm, Starhome Mach. Starhome enables seamless, secure roaming and Internet
Starhome Mach Snapped Up By Vista Equity Partners
Adv. Revital Katz from our Private Clients, Trusts & Estates Practice talks to Globes about what prompts people to prepare a will and
Herzog Fox & Neeman’s Revital Katz Talks Wills with Globes
Herzog Fox & Neeman’s Yair Geva, Yael Hauser and David Adler represented Forter raising USD 50 million in a series D funding round led by
Herzog Fox & Neeman Represents Forter in Series D Funding Round
Herzog Fox & Neeman represented Israeli food-delivery app, Tapingo, in its acquisition by Grubhub, online and mobile food-ordering and delivery
Herzog Fox & Neeman Represents Tapingo in Sale to Grubhub
Herzog Fox & Neeman acted as company counsel for Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), an Israeli clinical-stage specialty pharmaceutical company,


